Get started
Author

Rafaela Brito de Paula

Observed name: Rafaela Brito De Paula
Institution: AC Camargo Hospital
ORCID: 0000-0003-1515-6676
Observed ORCID: 0000-0003-1515-6676
OpenAlex ID: A5067097511
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
2025 · Li Zhou, Milton Jose Barros e Silva, et al. · Journal for ImmunoTherapy of Cancer · 22
PDF
Macroglossia and periorbital ecchymoses in a patient with systemic amyloidosis: A case report
2015 · Jamille Hemétrio Salles Martins Costa, Aloísio Benvindo de Paula, et al. · International Journal of Case Reports and Images · 6
PDF
Tumoural form of Whipple's disease simulating carcinomatosis
2014 · Jamille Hemétrio Salles Martins Costa, Aline Bussinger Maciel, et al. · The Brazilian Journal of Infectious Diseases · 4
PDF
Xeroderma pigmentosum: a 12-year experience in digital dermoscopy and reflectance confocal microscopy follow-up at a Cancer Center in Brazil
2025 · Joyce Gouvêa Freire, Tatiana Cristina Moraes Pinto Blumetti, et al. · Anais Brasileiros de Dermatologia · 2
Combined EORTC FDG-PET/CT and RECIST 1.1 response criteria and prediction of pathological response to neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma.
2024 · Milton Jose De Barros E Silva, Monique Celeste Tavares, et al. · Journal of Clinical Oncology · 2
Confocal reflectance microscopy in basal cell carcinoma associated with nevus sebaceous: case report
2024 · Ingrid Priscila Ribeiro Paes Ferraz, Gustavo Carvalho, et al. · Anais Brasileiros de Dermatologia · 1
Analysis of neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma using the SWOG S1801 event-free survival definition.
2024 · Milton Jose De Barros E Silva, Monique Celeste Tavares, et al. · Journal of Clinical Oncology · 1
PDF
FDG-PET/CT response and prediction of pathological response to neoadjuvant nivolumab and ipilimumab for clinical stage III melanoma.
2023 · Milton Jose De Barros E Silva, Monique Celeste Tavares, et al. · Journal of Clinical Oncology · 1
Xeroderma pigmentoso: experiência de 12 anos em seguimento por dermatoscopia digital e microscopia confocal de reflectância em um centro de câncer no Brasil
2025 · Joyce Gouvêa Freire, Tatiana Cristina Moraes Pinto Blumetti, et al. · Anais Brasileiros de Dermatologia (Versão em Português)
NEOSENT: Neoadjuvant anti-PD-1 therapy for patients with high-risk clinical stage II melanoma with a scheduled sentinel lymph node biopsy.
2025 · Milton Jose De Barros E. Silva, Matheus Lobo, et al. · Journal of Clinical Oncology
Multiple Primary Melanoma: A Five-Year Prospective Single-Center Follow-Up Study of Two MC1R R/R Genotype Carriers
2023 · Ana Maria Fagundes Sortino, Bianca Costa Soares de Sá, et al. · Life
PDF
Works count: 11
Citation count: 39
H-index: 3
I10-index: 1
Year
Topic
Type